MEP6308A - Granulirani preparati gaboksadola - Google Patents

Granulirani preparati gaboksadola

Info

Publication number
MEP6308A
MEP6308A MEP-63/08A MEP6308A MEP6308A ME P6308 A MEP6308 A ME P6308A ME P6308 A MEP6308 A ME P6308A ME P6308 A MEP6308 A ME P6308A
Authority
ME
Montenegro
Prior art keywords
gaboxadol
granular preparations
granular
preparations
Prior art date
Application number
MEP-63/08A
Other languages
English (en)
Inventor
Michiel Onne Elema
Lene Andresen
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MEP6308A publication Critical patent/MEP6308A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MEP-63/08A 2001-05-21 2002-05-17 Granulirani preparati gaboksadola MEP6308A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100817 2001-05-21
PCT/DK2002/000332 WO2002094225A1 (en) 2001-05-21 2002-05-17 Granular preparations of gaboxadol

Publications (1)

Publication Number Publication Date
MEP6308A true MEP6308A (xx) 2010-02-10

Family

ID=8160520

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-63/08A MEP6308A (xx) 2001-05-21 2002-05-17 Granulirani preparati gaboksadola

Country Status (26)

Country Link
US (1) US20040157876A1 (ru)
EP (1) EP1389091A1 (ru)
JP (1) JP2004530695A (ru)
KR (1) KR20030097890A (ru)
CN (1) CN1511026A (ru)
AR (1) AR033896A1 (ru)
AU (1) AU2002338855B2 (ru)
BG (1) BG108441A (ru)
BR (1) BR0209834A (ru)
CA (1) CA2447603A1 (ru)
CZ (1) CZ20033269A3 (ru)
EA (2) EA009731B1 (ru)
HR (1) HRP20030950A2 (ru)
HU (1) HUP0400051A2 (ru)
IL (1) IL158733A0 (ru)
IS (1) IS7020A (ru)
ME (1) MEP6308A (ru)
MX (1) MXPA03010596A (ru)
NO (1) NO20035146D0 (ru)
NZ (1) NZ547636A (ru)
PL (1) PL366541A1 (ru)
SK (1) SK15542003A3 (ru)
UA (1) UA80092C2 (ru)
WO (1) WO2002094225A1 (ru)
YU (1) YU92103A (ru)
ZA (1) ZA200308594B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022941A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
PT1641456E (pt) 2003-06-25 2010-06-01 Lundbeck & Co As H Gaboxadol para o tratamento de depressão e outros distúrbios afectivos
TW200528098A (en) * 2003-12-18 2005-09-01 Lundbeck & Co As H Treatment of insomnia in human patients
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1848420A4 (en) 2005-01-28 2008-01-23 Merck & Co Inc POLYMORPHIC FORMS OF A GABAA AGONIST
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
CA2725356C (en) * 2008-05-30 2018-10-16 Psychogenics, Inc. Use of eltoprazine for improving symptoms of cognitive impairment associated with non-adhd neurological and mental disorders
EP2334299A1 (en) * 2008-09-01 2011-06-22 H. Lundbeck A/S Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat
CA2859174C (en) 2011-12-12 2019-03-05 Orbis Biosciences, Inc. Sustained release particle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
WO2001022941A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
HRP20030950A2 (en) 2005-08-31
HUP0400051A2 (hu) 2004-04-28
EA200301282A1 (ru) 2004-04-29
NO20035146L (no) 2003-11-19
CZ20033269A3 (en) 2004-03-17
IS7020A (is) 2003-11-10
NZ547636A (en) 2008-03-28
WO2002094225A1 (en) 2002-11-28
SK15542003A3 (sk) 2004-05-04
CN1511026A (zh) 2004-07-07
CA2447603A1 (en) 2002-11-28
UA80092C2 (en) 2007-08-27
EP1389091A1 (en) 2004-02-18
ZA200308594B (en) 2004-11-04
JP2004530695A (ja) 2004-10-07
MXPA03010596A (es) 2004-03-09
IL158733A0 (en) 2004-05-12
BG108441A (en) 2005-02-28
NO20035146D0 (no) 2003-11-19
EA200700703A1 (ru) 2007-08-31
EA009731B1 (ru) 2008-02-28
BR0209834A (pt) 2004-06-15
AR033896A1 (es) 2004-01-07
PL366541A1 (en) 2005-02-07
YU92103A (sh) 2006-05-25
KR20030097890A (ko) 2003-12-31
US20040157876A1 (en) 2004-08-12
AU2002338855B2 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
EP1578910A4 (en) NITRILASES
GB2376583B (en) Time alignment of signals
IL157426A0 (en) Peg-conjugates of hgf-nk4
EP1420651A4 (en) PRESERVATION OF AGRICULTURAL PRODUCTS
IL158733A0 (en) Granular preparations of gaboxadol
AU2002359694A8 (en) Compounds and methods
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB0126889D0 (en) Compounds and their uses
GB0125708D0 (en) Novel compounds and processes
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
AU2002358719A1 (en) Agaricoglycerides and analogs
EP1379240A4 (en) CONNECTIONS AND METHODS
GB0100151D0 (en) Methods of sputtering
IL157243A0 (en) Preparation of n-methylparoxetine and related intermediate compounds
TW493722U (en) Improved structure of lampwick
AU2002359898A1 (en) Preparation of alpha-diimines
EP1435953A4 (en) ANTI-VESICANS COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE
HU0104370D0 (en) Honeyed schnaps of oerseg
AU150489S (en) Set of chamfered logs
TW573751U (en) Structure capable of preventing jaming
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
GB0104615D0 (en) Treatment of technetium
GB0105097D0 (en) Treatment of technetium
AU2002335011A1 (en) Compounds and methods